Tess Ames
27th April 2020

Azza Dammak joins ORBITAL | Researcher Blog

I am a pharmacist from Tunisia. I got my PharmD from the faculty of Pharmacy of Monastir in 2017

Then, obtained my master’s degree in biotechnology in the University of Paris Sud, France in 2018, and I completed to specialize in Pharmaceutical Technology Drug Delivery and Formulation at the Faculty of Pharmacy Grenoble Alpes, FranceAfter my master’s degree, I worked as Junior pharmaceutical Development Scientist in AAA Novartis Company. 

During my academic careerI did my internship in pharmaceutical industries, such as Pierre Fabre, Gattefossé, BMS UPSAI interned in Research Unitssuch as INSERM Paris, department of medical oncology and department of ophthalmology in Military Hospital.   

My thesis project was on the comparison between 2 nanobodies, Ranibizumab and Bevacizumab, for the treatment of Age-related Macular degeneration in the department of Ophthalmology 

My main research activity in Gattefossé Lyon, as an intern, was focused on the formulation of drugs and the optimisation of manufacturing processesI investigated the performance of lipid excipients in granulation and tableting. I participated in application laboratory program in oral and topic dosage forms which covers solubilitybio-availability enhancement and modified release. 



Azza joins ORBITAL

have gained information and experience from working in the field of Research and Development; now I am happy to start my PhD as part of Orbital Project and to focus more on innovative technologies.  

Actually, I am the ESR student for the Project 14. I am based in Madrid, and I am doing my doctorate in Ocupharm in collaboration with University of Complutense MadridThe topic of the project is about Development of a novel biomarker cocktail for the diagnosis-screening of drug delivery and treatment efficacy in age-related ocular diseases. 

Using a variety of present-day data, Ocupharm investigates the hypothesis of developing a cocktail of Biomarkers regrouping the most common age-related diseases such as Glaucoma, dry eyes and age– related macular degeneration. The first step in identifying suitable biomarkers is to understand the pathophysiology of the disease and to identify the factors associated with it. The next step is to identify potential biomarkers based on the mechanism.  

Training Programme and Teaching

In addition to the individual doctoral project, benefit from an exciting training programme consisting training activities related to the development of scientific knowledge and enhancement of transferable skills. Indeed, started teaching Biochemistry and Analytical Chemistry to 3 group of students in the faculty 

Finally, as live in Madrid, and to be more comfortable in my environment, I started learning Spanish last month. I hope to become quadrilingual by the end of the project 

The beginning was not easy, but I am sure the best is coming 

We have a podcast!

Listen to our channel to stay up-to-date on the latest in breakthroughs and technological advances in Ocular Drug Delivery Technology.